Encouraging Findings for Batten Disease Drug
The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH.
The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH.
New vaccine options offer protection against respiratory virus season's big three: COVID-19, RSV and the flu
Rush held a groundbreaking ceremony for the new Joan and Paul Rubschlager Building, the future home to Rush's neuroscience and cancer programs.
Kyla McDaniel benefitted from mentorship and now is a mentor herself through the REACH MedStem Pathways program
From surgeons to students, Team Rush runners are taking on the Chicago Marathon to raise funds for the programs and patients closest to their hearts.
In Rush Copley’s Movement Disorders Program, Terri Keckler found the physical activity she needed — and friendships, too
The first endowment for social work at Rush will strengthen programs that address the social drivers of health and expand care for patients and communities
Rush College of Nursing is proud to celebrate our distinguished alumni who continue to exemplify the impact of our educational mission
Chatka and Tony Ruggiero made a gift toward research that has shown promise in finding earlier signs of kidney disease
Rush Medical College students partner with homeless services provider Franciscan Outreach to offer COVID-19 screening and support